NCT04189042 is a clinical trial in Parkinson Disease, sponsored by Gazi University.

Who is sponsoring NCT04189042?

NCT04189042 is sponsored by Gazi University.

What condition does NCT04189042 study?

NCT04189042 studies Parkinson Disease.

Is NCT04189042 still recruiting?

NCT04189042 is currently status unknown. Last updated 4 February 2021.

Last reviewed 2021-02-04 · How we verify

NCT04189042

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Figure-of-Eight Walk Test in Parkinson

Status unknown Last updated 4 February 2021

What this trial tests

trial in Parkinson Disease in 30 participants. Status unknown.

Timeline

11 December 2019

Primary endpoint
30 March 2021

31 May 2021

Quick facts

Lead sponsor	Gazi University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	11 December 2019
Primary completion	30 March 2021
Estimated completion	31 May 2021
Sites	1 location across Turkey (Türkiye)

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

Gazi University

Who can join

40 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of study is to assess validity and reliability of Figure-of-Eight Walk Test in people with Parkinson's Disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other Gazi University trials

Trials by the same sponsor.

NCT07500857 — Gamification in Stoma Care Education for Nursing Students · NA · not yet recruiting
NCT07471737 — Patient Safety and Medical Errors in Nursing Education: Learning by Doing and Experiencing With Simulated Patients · NA · not yet recruiting
NCT07440563 — Auricular Vagus Nerve Stimulation Combined With Rehabilitation in Parkinson's Disease · NA · enrolling by invitation
NCT07496398 — Median and Ulnar Nerve Function in Tattoo Artists · recruiting
NCT07471386 — Adjunctive Keratinized Mucosa Augmentation in Peri-Implantitis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04189042 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gazi University
Last refreshed: 4 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04189042.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing